GB201803764D0 - Cancer targeting peptides and their use in delivering therapeutic cargo - Google Patents

Cancer targeting peptides and their use in delivering therapeutic cargo

Info

Publication number
GB201803764D0
GB201803764D0 GBGB1803764.8A GB201803764A GB201803764D0 GB 201803764 D0 GB201803764 D0 GB 201803764D0 GB 201803764 A GB201803764 A GB 201803764A GB 201803764 D0 GB201803764 D0 GB 201803764D0
Authority
GB
United Kingdom
Prior art keywords
targeting peptides
delivering therapeutic
cancer targeting
therapeutic cargo
cargo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1803764.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microquin
Original Assignee
Microquin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microquin filed Critical Microquin
Priority to GBGB1803764.8A priority Critical patent/GB201803764D0/en
Publication of GB201803764D0 publication Critical patent/GB201803764D0/en
Ceased legal-status Critical Current

Links

GBGB1803764.8A 2018-03-09 2018-03-09 Cancer targeting peptides and their use in delivering therapeutic cargo Ceased GB201803764D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1803764.8A GB201803764D0 (en) 2018-03-09 2018-03-09 Cancer targeting peptides and their use in delivering therapeutic cargo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1803764.8A GB201803764D0 (en) 2018-03-09 2018-03-09 Cancer targeting peptides and their use in delivering therapeutic cargo

Publications (1)

Publication Number Publication Date
GB201803764D0 true GB201803764D0 (en) 2018-04-25

Family

ID=61972802

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1803764.8A Ceased GB201803764D0 (en) 2018-03-09 2018-03-09 Cancer targeting peptides and their use in delivering therapeutic cargo

Country Status (1)

Country Link
GB (1) GB201803764D0 (en)

Similar Documents

Publication Publication Date Title
IL276464A (en) Methods and compositions for therapeutic protein delivery
GB201603568D0 (en) Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
IL269741A (en) Peptides and combination thereof for use in the immunotherapy against cancers
IL266623A (en) Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer
IL268687A (en) Antibody targeting il-13ra2 and use thereof
GB201604213D0 (en) Drug combination and its use in therapy
SG11202010212RA (en) Dual atm and dna-pk inhibitors for use in anti-tumor therapy
IL281495A (en) Quinuclidine-3-one derivatives and their use in cancer treatment
PL3758730T3 (en) Peptides and compositions for use in cosmetics and medicine
PT3432970T (en) In vivo drug delivery devices and methods for drug delivery
GB201820659D0 (en) Novel compostions and their use in therapy
EP3630099A4 (en) Bax activators and uses thereof in cancer therapy
EP3566710A4 (en) Therapeutic agent and application thereof in drugs for treating tumors and/or cancer
IL272397A (en) Optimized peptides for targeting human nerves and their use in image guided surgery, diagnostics and therapeutic delivery
IL274122A (en) Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
IL281919A (en) Combination therapy using anti-ssea-4 antibody in combination with therapeutic oncology agents
ZA201905372B (en) Therapeutic and neuroprotective peptides
EP3763731A4 (en) Hmgn partial peptide and cancer therapy using same
IL284981A (en) Semaphorin-4d antagonists for use in cancer therapy
IL248328A0 (en) Drug delivery conjugates for treating resistant cancer and for use in combination therapy
EP3753579A4 (en) Anti-trailr2 antibody-toxin-conjugate and pharmaceutical use thereof in anti-tumor therapy
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
GB201803764D0 (en) Cancer targeting peptides and their use in delivering therapeutic cargo
IL280555A (en) Substituted benzamides and their use in therapy
SG11202105276TA (en) Oligo-benzamide analogs and their use in cancer treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)